SETBP1 haploinsufficiency and related disorders clinical and neurobehavioral phenotype study

被引:0
|
作者
Oyler, Haley O. [1 ]
Hudac, Caitlin M. [2 ]
Chung, Wendy K. [3 ]
Green Synder, Leeanne [4 ]
Robertson, Stephanie [5 ]
Srivastava, Siddharth [6 ]
Geye, Trina [7 ]
机构
[1] SETBP1 Soc, Austin, TX 78703 USA
[2] Univ South Carolina, Carolina Autism & Neurodev Res Ctr, Dept Psychol, Columbia, SC USA
[3] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA USA
[4] Simons Fdn, New York, NY USA
[5] Tarleton State Univ, Tarleton Ctr Child Well Being, Dept Psychol, Stephenville, TX USA
[6] Boston Childrens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA USA
[7] Tarleton State Univ, Dept Psychol, Stephenville, TX USA
关键词
adaptive behavior; intellectual disability; neurodevelopmental disorders; phenotypic variability; SET-binding protein; speech or language developmental disorder; LANGUAGE DELAY; CHILDREN; SPEECH;
D O I
10.1111/cge.14579
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
To comprehensively investigate the neurodevelopmental profile and clinical characteristics associated with SETBP1 haploinsufficiency disorder (SETBP1-HD) and SETBP1-related disorders (SETBP1-RD). We reported genetic results on 34 individuals, with behavior and clinical data from 22 with SETBP1-HD and 5 with SETBP1-RD, by assessing results from medical history interviews and standardized adaptive, clinical, and social measures provided from Simons Searchlight. All individuals with SETBP1-HD and SETBP1-RD exhibited neurological impairments including intellectual disability/developmental delay (IDD), attention-deficit/hyperactivity disorder, autism spectrum disorder, and/or seizures, as well as speech and language delays. While restricted interests and repetitive behaviors present challenges, a relative strength was observed in social motivation within both cohorts. Individuals with SETBP1-RD reported a risk for heart issues and compared to SETBP1-HD greater risks for orthopedic and somatic issues with greater difficulty in bowel control. Higher rates for neonatal feeding difficulties and febrile seizures were reported for individuals with SETBP1-HD. Additional prominent characteristics included sleep, vision, and gastrointestinal issues, hypotonia, and high pain tolerance. This characterization of phenotypic overlap (IDD, speech challenges, autistic, and attention deficit traits) and differentiation (somatic and heart issue risks for SETBP1-RD) between the distinct neurodevelopmental disorders SETBP1-HD and SETBP1-RD is critical for medical management and diagnosis.
引用
收藏
页码:448 / 461
页数:14
相关论文
共 50 条
  • [21] Clinical, Laboratory, and Morphologic Features of Myeloid Malignancies with CSF3R and SETBP1 Mutation
    Chabot-Richards, D. S.
    Mahmoud, A. Z.
    Czuchlewski, D. R.
    Vasef, M. A.
    Maxson, J. E.
    Tyner, J. W.
    Arber, D. A.
    Gotlib, J.
    George, T. I.
    MODERN PATHOLOGY, 2014, 27 : 340A - 340A
  • [22] Identification of SETBP1 As an Epigenetic Hub Protein That Induces the Transcription of a Network of Development-Related Genes
    Piazza, Rocco
    Magistroni, Vera
    Redaelli, Sara
    Mauri, Mario
    Massimino, Luca
    Sessa, Alessandro
    Peronaci, Marco
    Lalowski, Maciej
    Soliymani, Rabah
    Mezzatesta, Caterina
    Pirola, Alessandra
    Banfi, Federica
    Rubio, Alicia
    Rea, Delphine
    Stagno, Fabio
    Usala, Emilio
    Martino, Bruno
    Campiotti, Leonardo
    Merli, Michele
    Passamonti, Francesco
    Onida, Francesco
    Morotti, Alessandro
    Pavesi, Francesca
    Bregni, Marco
    Broccoli, Vania
    Baumann, Marc
    Gambacorti-Passerini, Carlo
    BLOOD, 2017, 130
  • [23] 372 kb microdeletion in 18q12.3 causing SETBP1 haploinsufficiency associated with mild mental retardation and expressive speech impairment
    Marseglia, Giuseppina
    Scordo, Maria Rosaria
    Pescucci, Chiara
    Nannetti, Genni
    Biagini, Elisabetta
    Scandurra, Valeria
    Gerundino, Francesca
    Magi, Alberto
    Benelli, Matteo
    Torricelli, Francesca
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2012, 55 (03) : 216 - 221
  • [24] Clinical, Laboratory, and Morphologic Features of Myeloid Malignancies with CSF3R and SETBP1 Mutation
    Chabot-Richards, D. S.
    Mahmoud, A. Z.
    Czuchlewski, D. R.
    Vasef, M. A.
    Maxson, J. E.
    Tyner, J. W.
    Arber, D. A.
    Gotlib, J.
    George, T. I.
    LABORATORY INVESTIGATION, 2014, 94 : 340A - 340A
  • [25] Clinical Implications of the SETBP1 Mutation in Patients With Primary Myelodysplastic Syndrome and its Stability During Disease Progression
    Hou, H. A.
    Kuo, Y. Y.
    Tang, J. L.
    Chou, W. W.
    Yao, M.
    Lai, Y. L.
    Lin, C. C.
    Chen, C. Y.
    Liu, C. Y.
    Lee, M. C.
    Tseng, M. H.
    Huang, C. F.
    Chiang, Y. C.
    Lee, F. Y.
    Liu, M. C.
    Liu, C. Y.
    Huang, S. Y.
    Ko, B. S.
    Wu, S. J.
    Tsay, W.
    Chen, Y. C.
    Tien, H. F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S153 - S153
  • [26] Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
    Hou, Hsin-An
    Kuo, Yuan-Yeh
    Tang, Jih-Luh
    Chou, Wen-Chien
    Yao, Ming
    Lai, Yan-Jun
    Lin, Chien-Chin
    Chen, Chien-Yuan
    Liu, Chieh-Yu
    Tseng, Mei-Hsuan
    Huang, Chi-Fei
    Chiang, Ying-Chieh
    Lee, Fen-Yu
    Liu, Ming-Chih
    Liu, Chia-Wen
    Huang, Shang-Yi
    Ko, Bor-Sheng
    Wu, Shang-Ju
    Tsay, Woei
    Chen, Yao-Chang
    Tien, Hwei-Fang
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (02) : 181 - 186
  • [27] ASXL1 and SETBP1 Mutations and Their Prognostic Contribution in Chronic Myelomonocytic Leukemia: An International Study of 466 Patients
    Patnaik, Mrinal M.
    Itzykson, Raphael
    Lasho, Terra L.
    Kosmider, Olivier
    Finke, Christy M.
    Hanson, Curtis A.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Tefferi, Ayalew
    Solary, Eric
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S234 - S234
  • [28] Common variation within the SETBP1 gene is associated with reading-related skills and patterns of functional neural activation
    Perdue, Meaghan, V
    Mascheretti, Sara
    Kornilov, Sergey A.
    Jasinska, Kaja K.
    Ryherd, Kayleigh
    Mencl, W. Einar
    Frost, Stephen J.
    Grigorenko, Elena L.
    Pugh, Kenneth R.
    Landi, Nicole
    NEUROPSYCHOLOGIA, 2019, 130 : 44 - 51
  • [29] ASXL1 and SETBP1 Mutations and Their Prognostic Contribution In Chronic Myelomonocytic Leukemia: An International Study Of 431 Patients
    Patnaik, Mrinal M.
    Itzykson, Raphael
    Lasho, Terra L.
    Kosmider, Olivier
    Finke, Christy
    Hanson, Curtis A.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Tefferi, Ayalew
    Solary, Eric
    BLOOD, 2013, 122 (21)
  • [30] Clinical phenotype of ASD-associated DYRK1A haploinsufficiency
    Earl, Rachel K.
    Turner, Tychele N.
    Mefford, Heather C.
    Hudac, Caitlin M.
    Gerdts, Jennifer
    Eichler, Evan E.
    Bernier, Raphael A.
    MOLECULAR AUTISM, 2017, 8